United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
UTHR News
United Therapeutics Corporation ( ) shareholders would be excited to see that the share price has had a great month, posting a 38% gain and recovering from prio...
BTIG analyst Julian Harrison has maintained their neutral stance on UTHR stock, giving a Hold rating yesterday. Elevate Your Investing Strategy: Take advantage...
United Therapeutics Corporation UTHR released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution f...
Analyst ratings
67%
of 15 ratingsMore UTHR News
United Therapeutics (UTHR) stock rocketed higher on Tuesday after the biotechnology company announced the results of a Phase 3 clinical trial of nebulized Tyvas...
Markets reopened after the Labor Day break on softer footing, with futures tied to the major indexes pointing lower. Investors are balancing several pressures a...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
United Therapeutics (UTHR) announced that its TETON-2 study evaluating the use of nebulized Tyvaso Inhalation Solution for the treatment of idiopathic pulmonary...